Parallel export of a medicine on the list is considered a breach of regulation 43(2) of the Human Medicines Regulations 2012 and a contravention of the wholesale dealer licence and may lead to regulatory action by the Medicines and Healthcare products Regulatory Agency (MHRA), which could include immediate suspension of the wholesale dealer licence.
Four medicines have been added to the list of medicines that cannot be parallel exported from the UK: alprostadil, beclometasone dipropionate, noresthisterone and ranitidine. The date of restriction is 00:00am at the start of 18 October 2019.
The 'Date of publication' column has been removed from the list of medicines that cannot be parallel exported from the UK. This is to avoid confusion with the 'Date of restriction' column.
A link to guidance on 'Parallel export and hoarding of restricted medicines' has been added to the details text.
Added link to letter to holders of a wholesale dealer licence.